03

UBcare. Co. Ltd

032620 · KQ · Technology / Software & IT Services

2,915.00KRW+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close2,915.00
Open2,935.00
Day Range2,885.00 – 2,960.00
52-Week Range2,645.00 – 4,350.00
Volume20.22K
Market Cap163.02B
P/E (TTM)0.00
Forward P/E27.86
Dividend Yield1.28%
Beta1.34
50-Day Avg3,046.60
200-Day Avg3,538.70

About

UBcare. Co., Ltd. provides health care solutions in South Korea and internationally. The company offers medical IT services, such as Ysarang, an EMR system for hospital/clinic use; and U Pharm, an integrated management control system for pharmacies, hospitals, clinics, and pharmacy environments; and Big Ysarang, an EMR system for small and medium-sized hospitals, as well as customer management and media services. It is also involved in the medical distribution business that suggests products and services, such as high-technology medical equipment/devices for hospitals, clinics, pharmacies, medical e-commerce businesses, and shop-in-shop for health functional food; and provision of customized services. In addition, the company engages in the pharmaceutical marketing business; and provision of U-healthcare solution that offers digitalized hospital solution and healthcare service for personnel. Further, it operates digital hospital in Thailand. Its healthcare network covers 30,000 hospitals/clinics, pharmacies, 17 agencies, and 1.2 million members of healthkorea.net. The company was founded in 1992 and is based in Seoul, South Korea.

Company Details

  • SectorTechnology
  • IndustrySoftware & IT Services
  • CEOMr. Sang-Kyoung Lee
  • Employees296
  • HeadquartersWoolim e-Biz Center, Seoul, South Korea, 152-847, Korea
  • Websitehttps://www.ubcare.net

Leadership

  • Mr. Sang-Kyoung LeeChief Exec. Officer · b. 1966
  • Sung-Cheol HurExec. Officer
  • Mr. Shinooh KimExec. Officer · b. 1968
  • Tae-Man KwonManaging Director · b. 1960
  • Dong-Hwan AnManaging Director of Health Design Research Center · b. 1956
  • Hoon-Sub ShimExec. Officer
  • Byung-Chan KimExec. Officer
  • Yi-Seok KimExec. Officer
  • Sang-Min YeomExec. Officer
  • Yong-Hee YuExec. Officer

Financials

Income Statement

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue56.78B65.99B67.59B65.53B59.43B68.24B82.09B99.90B110.85B107.82B111.76B133.34B154.04B190.60B197.70B
Growth (%)-+16.22%+2.42%-3.05%-9.30%+14.83%+20.29%+21.69%+10.97%-2.74%+3.66%+19.31%+15.52%+23.73%+3.72%
Cost of Revenue22.09B29.63B28.57B28.07B25.71B30.71B39.61B49.45B54.96B48.91B52.86B65.52B73.12B94.95B95.75B
Gross Profit---34.15B33.72B37.53B42.48B50.45B55.90B58.91B58.90B67.82B80.92B95.65B101.94B
Gross Margin---52.12%56.74%55.00%51.75%50.50%50.42%54.64%52.70%50.86%52.53%50.18%51.57%
Operating Expense---29.49B29.19B31.39B36.19B38.85B43.54B43.35B48.26B59.24B77.53B90.48B94.19B
Operating Income3.17B559.92M362.89M4.66B4.53B6.14B6.29B11.60B12.35B15.56B10.64B8.58B3.39B5.16B7.75B
Operating Margin5.59%0.85%0.54%7.11%7.63%9.00%7.67%11.61%11.14%14.43%9.52%6.44%2.20%2.71%3.92%
EBITDA-----------11.10B8.05B10.07B49.13B
EBITDA Margin-----------8.33%5.22%5.28%24.85%
Net Income3.61B307.81M--2.59B6.21B5.07B3.56B5.77B6.80B6.23B13.31B3.59B-1.71B-1.59B36.98B
Net Income Margin6.36%0.47%--3.96%10.44%7.43%4.34%5.77%6.13%5.78%11.91%2.69%-1.11%-0.83%18.70%
R&D4.05B-93.69M-49.81M49.81M49.81M49.81M---289.26M1.66B1.62B2.99B
R&D as % of Total Revenue7.13%-0.14%-0.08%0.07%0.06%0.05%---0.22%1.08%0.85%1.51%
Interest Expense0000000020.46M59.93M255.18M379.79M720.45M1.47B1.66B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.02%0.06%0.23%0.28%0.47%0.77%0.84%

Balance Sheet

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets56.72B61.08B54.99B52.78B64.25B64.81B69.09B129.94B136.75B154.16B149.26B161.88B155.00B160.06B227.70B
Total Liabilities9.50B15.01B11.15B13.28B18.94B18.25B22.54B28.28B34.17B47.63B31.37B45.18B41.46B60.85B68.81B
Total Equity47.23B47.33B44.06B39.49B45.31B46.56B46.55B101.66B102.57B106.52B117.89B116.70B105.09B99.22B141.55B
Cash12.29B11.73B4.40B6.44B8.94B13.46B22.57B20.53B15.56B40.95B29.76B28.61B25.34B1.54M10.17B
Total Debt--------22.45M8.71B-----

Cash Flow

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow5.94B--5.20B7.80B3.13B9.35B8.40B11.79B11.76B7.94B4.25B2.49B2.35B16.63B
Investing Cash Flow-407.61M--3.16B-5.30B5.17B3.14B-56.68B-11.65B15.17B-16.47B-1.79B159.06M-1.71B-
Financing Cash Flow----3.78B-3.78B-3.78B-3.38B46.24B-5.10B-1.54B-2.66B-3.59B-5.92B-5.65B-
Capital Expenditure2.52B269.50M362.75M351.56M1.39B652.13M562.79M738.38M1.05B2.00B884.49M2.19B2.51B4.52B11.03B
Free Cash Flow--------11.81B8.83B5.72B2.00B-41.41M-3.94B5.60B
Dividends Paid---1.21B1.21B1.21B1.19B1.17B1.80B2.03B2.54B2.03B3.04B3.04B1.52B
FCF to OCF--------100.21%75.03%72.00%47.03%-1.66%-167.75%33.66%
Dividend Paid to FCF--------15.21%22.99%44.37%101.55%-7352.20%-77.27%27.20%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015May 16, 2016Aug 5, 2016Nov 4, 2016Feb 10, 2017May 2, 2017Aug 3, 2017Nov 3, 2017Feb 11, 2018May 4, 2018Aug 7, 2018Nov 1, 2018Feb 12, 2019Apr 19, 2019Aug 4, 2019Nov 3, 2019Feb 24, 2020Apr 26, 2020Jul 30, 2020Nov 1, 2020Feb 9, 2021Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------------------------------------------------------
EPS Actual8.0018.0012.0034.0010.0411.975.3137.9824.387.2425.6032.367.520.237.1622.7410.71-18.58-1.2131.50-117.0433.2527.6337.1547.3139.4016.7064.546.0030.3233.5437.68-11.4326.0039.0041.1213.0040.8152.0049.01-9.8256.0046.0079.00-57.92168.26-1.7548.0247.8122.4810.1750.08-12.0617.71-65.09-10.3223.97-6.43-20.72-12.418.3047.91713.0236.74-68.971.44-2.68
Surprise-------------------------------------------------------------------
Timing-------------------------Pre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-market-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hours----------------------

Key Statistics & Ratios

Market Cap163.02B
Enterprise Value161.43B
Trailing P/E0.00
Forward P/E27.86
Price / Sales0.76
Price / Book1.10
Revenue (TTM)128.00B
Gross Profit (TTM)58.81B
EBITDA9.95B
Profit Margin5.18%
Operating Margin5.16%
Return on Equity116.12%
Return on Assets2.72%
Shares Outstanding50.90M
Shares Float23.26M
Beta1.34
Dividend Yield1.28%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20261×
50.00Mar 30, 2026
20241×
30.00Dec 27, 2024
20231×
60.00Dec 27, 2023
20221×
60.00Dec 28, 2022
20211×
40.00Dec 29, 2021
20201×
50.00Dec 29, 2020
20191×
40.00Dec 27, 2019
20181×
35.00Dec 27, 2018
20171×
30.00Dec 27, 2017
20161×
30.00Dec 28, 2016
20151×
30.00Dec 29, 2015